Who
Valerie Denise Harding Start
Director
Company insider
Files Form 4 as: Director, Erasca; SVP, Chemistry, Mfg & Controls, Ignyta.
In numbers
- Trades disclosed
- 21
- Buys
- 3
- Sells
- 0
- Bought
- $97K
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 2 Sep 2015
- Last trade
- 26 Jun 2026
- Last filed
- 29 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 26 Jun 2026filed 29 Jun 2026 | ERAS Erascaoption or derivative · Biotechnology | SEC FORM 4 Code A | —29,888 at $0.00 | filing |
| 26 Jun 2026filed 29 Jun 2026 | ERAS Erascaoption or derivative · Biotechnology | SEC FORM 4 Code A | —29,888 at $0.00 | filing |
| 1 Jan 2026filed 5 Jan 2026 | ERAS Erascaoption or derivative · Biotechnology | SEC FORM 4 Code A | —24,306 at $0.00 | filing |
| 1 Jan 2026filed 5 Jan 2026 | ERAS Erascaoption or derivative · Biotechnology | SEC FORM 4 Code A | —24,306 at $0.00 | filing |
| 24 Jun 2025filed 26 Jun 2025 | ERAS Erascaoption or derivative · Biotechnology | SEC FORM 4 Code A | —120,000 at $0.00 | filing |
| 1 Jan 2025filed 2 Jan 2025 | ERAS Erascaoption or derivative · Biotechnology | SEC FORM 4 Code A | —29,402 at $0.00 | filing |
| 20 Jun 2024filed 21 Jun 2024 | ERAS Erascaoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 1 Jan 2024filed 3 Jan 2024 | ERAS Erascaoption or derivative · Biotechnology | SEC FORM 4 Code A | —39,590 at $0.00 | filing |
| 6 Dec 2023filed 8 Dec 2023 | ERAS ErascaBiotechnology | SEC FORM 4 Bought | $19K10,000 at $1.85 | filing |
| 22 Jun 2023filed 26 Jun 2023 | ERAS Erascaoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 21 Dec 2022filed 22 Dec 2022 | ERAS ErascaBiotechnology | SEC FORM 4 Bought | $46K10,000 at $4.64 | filing |
| 22 Jun 2022filed 24 Jun 2022 | ERAS Erascaoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 20 Jul 2021filed 20 Jul 2021 | ERAS ErascaBiotechnology | SEC FORM 4 Bought | $32K2,000 at $16.00 | filing |
| 8 Feb 2018filed 12 Feb 2018 | Ignytaoption or derivative | SEC FORM 4 Code D | —200,000 at $0.00 | filing |
| 8 Feb 2018filed 12 Feb 2018 | Ignytaoption or derivative | SEC FORM 4 Code D | —50,000 at $0.00 | filing |
| 8 Feb 2018filed 12 Feb 2018 | Ignyta | SEC FORM 4 Code D | $788K29,188 at $27.00 | filing |
| 26 Dec 2017filed 28 Dec 2017 | Ignyta | SEC FORM 4 Code F | $55K2,066 at $26.70 | filing |
| 22 Dec 2017filed 22 Dec 2017 | Ignyta | SEC FORM 4 Code A | —23,334 at $0.00 | filing |
| 5 Jan 2017filed 6 Jan 2017 | Ignytaoption or derivative | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 7 Jan 2016filed 11 Jan 2016 | Ignyta | SEC FORM 4 Code A | —7,920 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.